VIR FY 2025 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena

VIRVir Biotechnology, Inc.

$1B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$69M-7.6% YoY

Gross Profit

$57M82.9% margin

Operating Income

-$468M-682.7% margin

Net Income

-$438M-638.9% margin

EPS (Diluted)

$-3.16

Cash Flow

Operating Cash Flow

-$392M

Free Cash Flow

-$397M

Stock-Based Comp.

$49M

Balance Sheet

Total Assets

$1.0B

Total Liabilities

$238M

Stockholders' Equity

$765M

Cash & Equivalents

$234M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$69M	$74M	-7.6%
Gross Profit	$57M	-$404M	+114.1%
Operating Income	-$468M	-$587M	+20.3%
Net Income	-$438M	-$522M	+16.1%